Risk-Adapted Preemptive Therapy for Cytomegalovirus Diseases after Allogeneic Hematopoietic Stem Cell Transplantation

被引用文献2件参考文献5件

MORI Takehiko

Division of Hematology, Department of Medicine, Keio University School of Medicine
AISA Yoshinobu

Division of Hematology, Department of Medicine, Keio University School of Medicine
NAKAZATO Tomonori

Division of Hematology, Department of Medicine, Keio University School of Medicine
IKEDA Yasuo

Division of Hematology, Department of Medicine, Keio University School of Medicine
OKAMOTO Shinichiro

Division of Hematology, Department of Medicine, Keio University School of Medicine